![Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs - ScienceDirect Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422000460-ga1.jpg)
Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs - ScienceDirect
![Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function - ScienceDirect Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1097276517309814-fx1.jpg)
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function - ScienceDirect
![Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling | Modern Pathology Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2017.174/MediaObjects/41379_2018_Article_BFmodpathol2017174_Fig2_HTML.jpg)
Expression of enhancer of zeste homolog 2 (EZH2) protein in histiocytic and dendritic cell neoplasms with evidence for p-ERK1/2-related, but not MYC- or p-STAT3-related cell signaling | Modern Pathology
![An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1 | ACS Chemical Biology An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1 | ACS Chemical Biology](https://pubs.acs.org/cms/10.1021/cb400133j/asset/images/medium/cb-2013-00133j_0001.gif)